Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model

Table 1 Base case input parameters

Base Case Modifiable Inputs
	LFA	RIS-LAI	RIS-SOT	Source
Adherence	1.0*	0.85*	0.65**	** [21]
Annual Discontinuation (Persistence)	0.30	0.50	0.64	[20, 23]
Annual Relapse Rates
When Adherent	10.10%			[15]
When Non-adherent	78.70%
Proportion of Relapses Inpatient	0.53
Utilities
	While Stable	In Inpatient Relapse	In Outpatient Relapse
Adherent	0.88	0.53	0.74	[24]
Non-adherent	0.75	0.42	0.63
Execution
Model Timeframe	5 years			N/A
Cycle Length	1.0 months
Discount rate (costs)	3%

ISSN: 1744-859X